托皮拉酸盐用于治疗新生儿发作及其他疾病
Wolfgang Löscher1,2, Janet S Soul3,4
1Translational Neuropharmacology Lab, NIFE, Department of Experimental Otology of the ENT Clinics, Hannover Medical School, Hannover, Germany.
Epilepsia
|July 31, 2025
概括
托皮拉 (TPM) 显示出对治疗新生儿发作耐药的标准药物有前途. 新的静脉注射配方正在开发中,以提高安全性和有效性,并可能增强新生儿的神经保护.
科学领域:
- 新生儿神经学 新生儿神经学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 新生儿发作是常见的,并且往往耐受于第一线治疗,如巴比特 (PB).
- 现有的抗发作药物 (ASM) 携带短期和长期不良影响的风险,包括神经发育问题.
- 对于新生儿发作来说,急需更安全,更有效的ASM.
研究的目的:
- 审查关于新生儿发作托皮拉 (TPM) 的当前知识.
- 突出TPM作为辅助疗法的潜力,特别是其神经保护性质.
- 讨论新的静脉TPM配方和未来的研究方向.
主要方法:
- 对新生儿发作TPM的临床前和临床数据的审查.
- 讨论TPM的多式联络机制的作用和神经保护作用.
- 新兴静脉TPM配方的描述.
主要成果:
- TPM对PB耐药新生儿发作表现出有希望的临床前和临床发现.
- TPM的神经保护活性可能会增加治疗性低温症在缓解新生儿脑损伤方面的有效性.
- 新型静脉TPM配方正在开发中,其中一种配方使用新生儿适合性的梅格卢明.
结论:
- 静脉TPM是新生儿发作的有前途的治疗选择,解决目前治疗方法的局限性.
- 需要进一步的研究,包括随机对照试验,以确定静脉TPM的最佳剂量和疗效.
- 在新生儿发作和相关脑损伤的试验中,TPM的神经保护潜力值得研究.
相关概念视频
Antiepileptic Drugs: Sodium Channel Blockers
890
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
890
Antiepileptic Drugs: GABAergic Pathway Potentiators
653
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
653
Antiepileptic Drugs: Glutamate Antagonists
517
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
517
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
451
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
451
Antiepileptic Drugs: Calcium Channel Blockers
632
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
632
Antiepileptic Drugs: Potassium Channel Activators
278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
278


